Forschungslaborprojekt eines multinationalen Pharmaunternehmens

1. Project Overview

A leading multinational pharmaceutical company embarked on a strategic initiative to establish a state-of-the-art research laboratory in [Location – e.g., Singapore, Boston, or Shanghai]. The facility was designed to support early-stage drug discovery, formulation development, and potency analysis for novel oncology and gene therapy products.

To meet stringent regulatory requirements (EU GMP, FDA cGMP, and ISO 14644), the company required a fully integrated cleanroom equipment solution capable of achieving ISO Class 5 to ISO Class 7 environments, with specialized containment for highly potent active pharmaceutical ingredients (HPAPIs).

2. Client Requirements

• Strict Contamination Control: Prevention of cross-contamination between different research modules (e.g., cell culture, virology, and chemical synthesis).

• High Containment: Negative pressure suites with HEPA/ULPA filtration and pass-through systems for handling OEB Level 4 and 5 compounds.

• Precision Environmental Control: Temperature stability at $21\pm 1^{\circ }C$, relative humidity $45\pm 5\%$und Raumdruckkaskade von sauberen zu schmutzigen Korridoren.

• Modular Scalability: Ability to expand or reconfigure lab modules without major renovation.

• Datenintegrität & Überwachung:  Kontinuierliche Überwachung der Partikelzahl, des Differenzdrucks und der Luftströmungsgeschwindigkeit.

3. Cleanroom Equipment Engineering Solution

Our engineering team delivered a turnkey cleanroom equipment package comprising:

A. HVAC and Filtration Systems

• AHUs with Energy Recovery: Redundant air handling units with VFD-controlled fans.

• HEPA Filter Ceiling Modules: Terminal HEPA filters (99.997% @ 0.3 µm) with leak-tested housings.

• Einrichtungsluftströmungseinheiten (UDAFs):  Installiert über Biosicherheitsschränke und Tankstellen zur Aufrechterhaltung von ISO-Klasse 5-Zonen.

B. Modular Cleanroom Architecture

• Hardwall Modular Panels: Non-porous, chemical-resistant polyurethane or mineral core panels with rounded cove corners for easy cleaning.

• Interlocking Air-Tight Doors: With magnetic gaskets and vision panels.

• Pass-Through Chambers: Interlocked, HEPA-filtered pass-boxes for safe material transfer.

C. Containment and Safety Equipment

• Biosafety Cabinets (BSC Class II Type B2): 100% exhaust units connected to dedicated containment ducts.

• Pulveraufbewahrungshauben:  Downflow-Kabinen (DFB) zum Wiegen und Abgeben von HPAPIs.

• Bag-In/Bag-Out (BIBO) Filter Housings: For safe filter replacement without operator exposure.

D. Monitoring and Control System (BMS/EMS)

• Real-time sensors for particle count, differential pressure, temp/RH.

• Alarm and alert integration with the client’s central SCADA system.

• Data logging compliant with 21 CFR Part 11.

4. Key Engineering Challenges & Solutions

5. Validierung & Einhaltung

Alle Reinraumausrüstung wurde installiert und nach V-Modell  Ansatz:

• DQ (Design Qualification): Verified ISO class, material compatibility, and airflow simulations.

• IQ (Installationsqualifikation): Verified utility connections, filter integrity, and component certification.

• OQ (Operational Qualification):  Geprüfte Luftströmungsgeschwindigkeit, Druckkaskade, Partikelzahl (nicht durchführbar) und Alarmfunktionalität.

• PQ (Performance Qualification): Dynamic testing under simulated operational conditions, including aseptic media fills.

Result: The facility passed regulatory inspection with zero major observations, and achieved ISO 14644-1 Class 5 (at rest/in operation) for critical zones.

6. Project Outcome

• Completion Time: 14 months (on schedule)

• Cleanroom Area: 2,800 m² (including 12 modular labs and 4 support zones)

• Energieeffizienz:  28% Reduzierung des HVAC-Energieverbrauchs im Vergleich zu herkömmlichen Konstruktionen

• Operational Readiness: Successful commissioning of 8 HPAPI containment suites

Der Kunde betreibt nun ein flexibel, sicher und konform  Forschungslabor, beschleunigt seine Onkologie Pipeline mit minimiertem Kreuzkontamination Risiko.

7. Conclusion

This case study demonstrates that for multinational pharmaceutical R&D projects, engineered cleanroom equipment—not just construction—is the cornerstone of regulatory compliance and operational excellence. By integrating modular hardwall systems, precision HVAC, and real-time monitoring, the project met all scientific, safety, and scalability requirements.